JP2014514365A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014514365A5 JP2014514365A5 JP2014510747A JP2014510747A JP2014514365A5 JP 2014514365 A5 JP2014514365 A5 JP 2014514365A5 JP 2014510747 A JP2014510747 A JP 2014510747A JP 2014510747 A JP2014510747 A JP 2014510747A JP 2014514365 A5 JP2014514365 A5 JP 2014514365A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- linker
- compound
- medicament
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161485898P | 2011-05-13 | 2011-05-13 | |
| EP11165994 | 2011-05-13 | ||
| US61/485,898 | 2011-05-13 | ||
| EP11165994.2 | 2011-05-13 | ||
| PCT/EP2012/058762 WO2012156308A1 (en) | 2011-05-13 | 2012-05-11 | High-affinity, dimeric inhibitors of psd-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014514365A JP2014514365A (ja) | 2014-06-19 |
| JP2014514365A5 true JP2014514365A5 (enExample) | 2015-06-25 |
| JP6084207B2 JP6084207B2 (ja) | 2017-02-22 |
Family
ID=44367299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014510747A Active JP6084207B2 (ja) | 2011-05-13 | 2012-05-11 | 虚血性脳損傷及び疼痛治療用の効率的な神経保護剤としてのｐｓｄ−９５の高親和性二量体阻害剤 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2707014B1 (enExample) |
| JP (1) | JP6084207B2 (enExample) |
| KR (1) | KR102046830B1 (enExample) |
| CN (1) | CN103533949B (enExample) |
| AU (1) | AU2012257774C1 (enExample) |
| BR (1) | BR112013029206B1 (enExample) |
| CA (1) | CA2833515C (enExample) |
| DK (1) | DK2707014T3 (enExample) |
| ES (1) | ES2544573T3 (enExample) |
| IL (1) | IL228893B (enExample) |
| PL (1) | PL2707014T3 (enExample) |
| SG (1) | SG194717A1 (enExample) |
| WO (1) | WO2012156308A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6633523B2 (ja) | 2013-12-01 | 2020-01-22 | ユニバーシティ オブ コペンハーゲン | Ｐｓｄ−９５の二量体阻害剤脂肪酸誘導体 |
| CN103804500B (zh) * | 2014-01-22 | 2015-12-30 | 广州军区广州总医院 | 用于治疗慢性疼痛的多肽 |
| DK3149048T3 (en) * | 2014-05-28 | 2020-04-14 | Nono Inc | Chloridsalt af tat-nr2b9c |
| KR102403089B1 (ko) | 2017-07-05 | 2022-06-02 | 바이오셀즈(베이징) 바이오테크 코., 엘티디. | 폴리펩타이드의 약학적으로 허용 가능한 염 및 이의 용도 |
| JP7073486B2 (ja) | 2017-09-30 | 2022-05-23 | ▲拝▼西欧斯（北京）生物技▲術▼有限公司 | 興奮性神経毒性に関連した損傷の治療用ペプチド組成物 |
| AU2019214252B2 (en) | 2018-02-02 | 2024-04-04 | Københavns Universitet | Compounds for the treatment of acute brain injury |
| CN110627877A (zh) * | 2019-09-25 | 2019-12-31 | 成都奥达生物科技有限公司 | 一种psd-95抑制剂 |
| CN110787284A (zh) * | 2019-11-23 | 2020-02-14 | 胡书群 | 一种治疗缺血性脑损伤的混合小肽tat-shc及其应用 |
| EP4077354A4 (en) * | 2019-12-20 | 2024-01-24 | Pyc Therapeutics Limited | NEW CELLULAR DELIVERY PROCESSES |
| CN111285923B (zh) * | 2020-03-05 | 2023-02-03 | 成都奥达生物科技有限公司 | 一种psd-95抑制剂 |
| KR20230141958A (ko) * | 2021-01-08 | 2023-10-10 | 노노 인코포레이티드 | 개선된 치료 지수를 위한 플라스민-내성 펩티드 |
| TW202306965A (zh) | 2021-05-12 | 2023-02-16 | 哥本哈根大學 | Ｐｓｄ－９５抑制劑及其用途 |
| CN114533874B (zh) * | 2022-01-27 | 2023-12-29 | 北京和舆医药科技有限公司 | Psd-95 gk结构域作为神经保护靶点的用途 |
| WO2024222819A1 (zh) * | 2023-04-26 | 2024-10-31 | 深圳信立泰药业股份有限公司 | 一种psd-95结构域抑制剂、其制备方法及其用途 |
| CN117903259B (zh) * | 2023-09-07 | 2024-09-20 | 湖南中晟全肽生物科技股份有限公司 | 一种psd-95抑制剂及其用途 |
| CN119569824A (zh) * | 2023-09-07 | 2025-03-07 | 湖南中晟全肽生物科技股份有限公司 | 作为神经保护剂的药用化合物及其应用 |
| CN117164725B (zh) * | 2023-09-07 | 2024-05-10 | 湖南中晟全肽生物科技股份有限公司 | 一种突触后密度蛋白-95抑制剂多肽 |
| WO2025215348A1 (en) * | 2024-04-08 | 2025-10-16 | The Boots Company Plc | Skin wound treatment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7510824B2 (en) * | 1999-06-02 | 2009-03-31 | Nono Inc. | Method of screening peptides useful in treating traumatic injury to the brain or spinal cord |
| US20090285780A1 (en) | 2006-05-24 | 2009-11-19 | Chyi Lee | Peg linker compounds and biologically active conjugates thereof |
| DK2043671T3 (da) * | 2006-07-11 | 2020-06-15 | Nono Inc | Peptid og sammensætning deraf til anvendelse ved behandling af slagtilfælde med feber |
| US8080518B2 (en) * | 2007-12-05 | 2011-12-20 | Arbor Vita Corporation | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| DK2320927T3 (en) * | 2008-07-09 | 2015-09-14 | Univ Copenhagen | Modified peptides as potent inhibitors of the PSD-95 / NMDA receptor interaction |
-
2012
- 2012-05-11 ES ES12720862.7T patent/ES2544573T3/es active Active
- 2012-05-11 PL PL12720862T patent/PL2707014T3/pl unknown
- 2012-05-11 DK DK12720862.7T patent/DK2707014T3/en active
- 2012-05-11 EP EP12720862.7A patent/EP2707014B1/en active Active
- 2012-05-11 CN CN201280023754.8A patent/CN103533949B/zh active Active
- 2012-05-11 WO PCT/EP2012/058762 patent/WO2012156308A1/en not_active Ceased
- 2012-05-11 KR KR1020137031532A patent/KR102046830B1/ko active Active
- 2012-05-11 CA CA2833515A patent/CA2833515C/en active Active
- 2012-05-11 JP JP2014510747A patent/JP6084207B2/ja active Active
- 2012-05-11 BR BR112013029206-7A patent/BR112013029206B1/pt active IP Right Grant
- 2012-05-11 SG SG2013080718A patent/SG194717A1/en unknown
- 2012-05-11 AU AU2012257774A patent/AU2012257774C1/en active Active
-
2013
- 2013-10-15 IL IL228893A patent/IL228893B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014514365A5 (enExample) | ||
| MX353067B (es) | Composiciones de peptidos de glp-1 y preparaciones de las mismas. | |
| RU2015146614A (ru) | Конъюгированная вакцина на основе пептида антигена wt1 | |
| SG194717A1 (en) | High-affinity, dimeric inhibitors of psd-95 as efficient neuroprotectants againstischemic brain damage and for treatment of pain | |
| RU2016146198A (ru) | Терапевтические dll4-связывающие белки | |
| EP3428181A3 (en) | Anti-inflammatory peptides and composition comprising the same | |
| JP2010515686A5 (enExample) | ||
| EP3428182A3 (en) | Anti-inflammatory peptides and composition comprising the same | |
| WO2016118014A3 (en) | Anti-senescence compounds and uses thereof | |
| JP2015520184A5 (enExample) | ||
| EA201201446A1 (ru) | Пептидные производные, их получение и применение | |
| MY171100A (en) | Anti-ceacam5 antibodies and uses thereof | |
| JP2014520120A5 (enExample) | ||
| EP2390265A3 (en) | Insulinotropic peptide derivative wherein its N-terminal amino acid is modified | |
| JP2019513752A5 (enExample) | ||
| JP2013541521A5 (enExample) | ||
| CL2019003441A1 (es) | Puestos de mic-1 y usos de estos. | |
| RU2011123700A (ru) | Нонапептид с противоопухолевой активностью | |
| NZ593524A (en) | A nonapeptide with anti-tumour activity | |
| RU2016130448A (ru) | Пептидные дендримеры, содержащие фибриноген-связывающие пептиды | |
| RU2013139302A (ru) | Новые синтетические пептиды и их применение | |
| JP2015521206A5 (enExample) | ||
| NZ756128A (en) | Novel peptides and analogs for use in the treatment of oral mucositis | |
| JP2015517484A5 (enExample) | ||
| EA201391387A1 (ru) | Нейропротекторные пептиды |